New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a new liquid biopsy test that can be used to predict risk of early disease progression in women with metastatic breast cancer. This could help oncologists by optimizing the use of available and effective therapies with the goal of achieving better clinical outcomes and prolonging survival. Read more about the study here.
SEE ALL NEWS
Recent Posts
5 Healthy Habits That Help During Cancer Treatment
Understanding Mammogram Results
A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine
Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells
Ultra-Processed Foods: Q&A with 2 Dietitians
Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers
‘Power Surges’ on Cancer Cell Membranes May Fuel Progression of Disease
New Cancer Target Discovered
How surgeons build a new bladder for cancer patients like Deion Sanders